Grant, Robert M.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 5,096

Knowledge and the firm: Overview

Spender, J. ‐., & Grant, R. M. (1996) · Strategic Management Journal

Innovation and Knowledge ManagementKnowledge Management and Sharing

Cited by 1,463

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 602

Are Firms Superior to Alliances and Markets? An Empirical Test of Cross-Border Knowledge Building

Almeida, P., Song, J., & Grant, R. M. (2002) · Organization Science

Innovation and Knowledge ManagementInternational Business and FDI

Cited by 442

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER) primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 428

The knowledge based view and global strategy: Past impact and future potential

Grant, R., & Phene, A. (2022) · Global Strategy Journal

Innovation and Knowledge ManagementInternational Business and FDI

Cited by 180

Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.

Grohskopf, L. A., Chillag, K. L., Gvetadze, R., Liu, A. Y., Thompson, M., Mayer, K. H., Collins, B. M., Pathak, S. R., O'Hara, B., Ackers, M. L., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 172

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.

Solomon, M. M., Mayer, K. H., Glidden, D. V., Liu, A. Y., McMahan, V. M., Guanira, J. V., Chariyalertsak, S., Fernandez, T., Grant, R. M., Bekker, L.-G., et al. (2014) · Clinical Infectious Diseases

HIV/AIDS Research and InterventionsSyphilis Diagnosis and Treatment

Cited by 159

The epidemiology of 5-methoxy- N, N -dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018) · Journal of Psychopharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 140